Condition

Antibody-drug Conjugates clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Antibody-drug Conjugates clinical trials that are recruiting, in China. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Antibody-drug Conjugates clinical trials

StudyPhaseWhereStatusRegistered
Trastuzumab rezetecan for HER2-positive advanced solid tumors resistant to standard treatments Phase 2 Shanghai, Shanghai Municipality Recruiting Dec 30, 2025
Compression stockings to prevent peripheral neuropathy in patients receiving MMAE-containing ADCs for urothelial cancer — Shanghai Recruiting Sep 10, 2025
Exploring treatment strategies for HER2-low breast cancer using antibody-drug conjugates — Guangzhou, Guangdong Recruiting Mar 14, 2025

All recruiting trials (3)

Related topics

Advanced Solid Tumor CancerAdvanced Solid TumorsBreast NeoplasmsChemotherapy-induced Peripheral NeuropathyHER2-low Breast CancerUrachal CancerUrothelial CarcinomaTrastuzumab

Quick answers

How many Antibody-drug Conjugates clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.